Wright Medical Group Reaches Financial Agreement With BioMimetic’s CEO

Spinal Tech

Medical device maker Wright Medical Group has agreed to buy BioMimetic Therapeutics for $380 million and has reached a financial agreement with Sam Lynch, MD, BioMimetic CEO, according to the Nashville Business Journal. Dr. Lynch will receive a $1.25 million bonus for work related to the augment bone graft device. He will also receive $160,275 for unused vacation and $261,632 as a bonus for the year.

More Articles on Devices:
Ohio Third Frontier Gives $3M to Medical Device Partnership Fund
Dr. Paul Sawin Performs First Spine Surgery With PCM Cervical Disc
9 Orthopedic Devices Launched, Cleared in December

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers